Dawnzera showed an 81% reduction in the four-weekly rate of HAE attacks compared to placebo
Category: News
Ovarian cancer is the fifth leading cause of deaths from cancer in women
The vaccine could be created as a ready-to-use product, rather than needing to be personalised
The PM Awards celebrate creativity in pharmaceutical marketing and healthcare communications
More than 71% of patients treated with Unloxcyt achieved disease control
The firm already has a number of offices across the UK and Europe
The collaboration will help to advance a pipeline of antibody candidates
Company prepares marketing submission after treatment shows strong efficacy
Decision introduces zolbetuximab for eligible patients in NHS Scotland
Dysport reduces muscle contractions by blocking the transmission of nerve impulses